FREE WEBINAR – COVID-19 MONOCLONAL ANTIBODY THERAPIES AND THE COMBINATION DRUGS

The NC Health Care Facilities Association would like to invite representatives of North Carolina’s skilled nursing facilities, including and especially Medical Directors, to attend a virtual meeting with North Carolina Public Health Pharmacist, Tim Davis, on Thursday, January 7, at 3pm.  During this webinar, he will share information about COVID-19 monoclonal antibody therapies bamlanivimab (Eli Lilly mAb) and the combination drugs casirivimab and imdevimab (commonly referred to as Regeneron).  Specifically, the objectives for the session are:

• Review Emergency Use Authorizations (EUA) and clinical indications for COVID-19 monoclonal antibody therapies.
• Discuss COVID-19 monoclonal antibody supply chain/logistics and how skilled nursing facilities can gain access to these products for their patients.
• Share tools & resources available related to COVID-19 monoclonal antibody therapies.
• Answer any questions the audience may have related to COVID-19 monoclonal antibody therapies.

We encourage you to join this session on Thursday.  You can register by clicking here.